Respiratory and anaesthesia company The CAREstream Group revealed on Friday the completion of the acquisition of Christie Medical Holdings Inc from Christie Digital Systems Inc, a visual technologies company and a subsidiary of Ushio Inc, Japan.
In conjunction with the sale, Paul Damiani, one of CAREstream's senior group members, has been elected as president of Christie Medical Holdings and be responsible for all aspects of the business.
Based in Memphis, TN, Christie Medical Holdings Inc is a global company that discovers, develops and commercialises medical technologies. Its two dominant products are the VeinViewer Vision 2, the optimal vein finder device for hospitals and institutions and the VeinViewer Flex, a portable vascular visualization device.
The financial details of the sale were not disclosed by the companies.
Roivant to announce Q3 2026 financial results
Avacta secures FDA clearance for second pre|CISION oncology programme
OncoHost receives BIG Innovation Award in Health category
Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Antin to acquire clinical trial equipment provider Emsere
Merck completes acquisition of Cidara Therapeutics for USD9.2bn
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
INOVIO's INO-3107 Biologics License Application accepted by US FDA
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA